Non-CKD patients showed a trend towards numerically higher aldosterone receptor antagonist therapy than CKD patients (31% vs. 13%, p = 0.089). No differences were found in potassium levels, beta-blocker, ACE/AT1 inhibitor, amiodarone, and diuretics. Here, ACE is linked to chronic kidney disease.